Wave Life Sciences WVE Business Segments
| FY'25 | FY'24 | FY'23 | ||
|---|---|---|---|---|
| Research And Development Expense by Product | ||||
| AATD Program | $5.71M-51.0% | $11.67M+38.0% | $8.45M+125% | |
| INHBE Program | $15.72M+69.1% | $9.29M+3,959% | $229K— | |
| Income Tax Reconciliation Other Reconciling Items by Geography | ||||
| GB | $59K— | —— | —— | |
| US | $2.3M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Wave Life Sciences break its business down?
- Wave Life Sciences (WVE) reports research and development expense by product across 5 parts — AATD Program, DMD Programs, HD Programs, INHBE Program and Other Research And Development Expenses Including PNPLA3Additional Preclinical Programs PRISM. Each is extracted from the segment footnotes and tracked over time.
- Where does Wave Life Sciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Wave Life Sciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
